Found: 99
Select item for more details and to access through your institution.
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
- By:
- Publication type:
- Article
Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. E504, doi. 10.1002/ajh.24548
- By:
- Publication type:
- Article
Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 10, p. 864, doi. 10.1002/ajh.24098
- By:
- Publication type:
- Article
Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy.
- Published in:
- Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41687-020-00227-4
- By:
- Publication type:
- Article
Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events.
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0086-x
- By:
- Publication type:
- Article
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.
- Published in:
- BMC Medical Genomics, 2010, v. 3, p. 60, doi. 10.1186/1755-8794-3-60
- By:
- Publication type:
- Article
Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.636675
- By:
- Publication type:
- Article
Lessons learned from conducting the first cancer care delivery trial in the Alliance for Clinical Trials in Oncology (Alliance A191402CD).
- Published in:
- Clinical Trials, 2023, v. 20, n. 5, p. 559, doi. 10.1177/17407745231167123
- By:
- Publication type:
- Article
Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials.
- Published in:
- Clinical Trials, 2022, v. 19, n. 3, p. 274, doi. 10.1177/17407745221093922
- By:
- Publication type:
- Article
Effects of patient-reported outcome assessment order.
- Published in:
- Clinical Trials, 2022, v. 19, n. 3, p. 307, doi. 10.1177/17407745211073788
- By:
- Publication type:
- Article
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- Published in:
- Clinical Trials, 2021, v. 18, n. 1, p. 104, doi. 10.1177/1740774520975120
- By:
- Publication type:
- Article
Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events: Methods for item selection in industry-sponsored oncology clinical trials.
- Published in:
- Clinical Trials, 2018, v. 15, n. 6, p. 616, doi. 10.1177/1740774518799985
- By:
- Publication type:
- Article
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
- Published in:
- Clinical Trials, 2018, v. 15, n. 6, p. 624, doi. 10.1177/1740774518795637
- By:
- Publication type:
- Article
Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE.
- Published in:
- Clinical Trials, 2017, v. 14, n. 3, p. 255, doi. 10.1177/1740774517698645
- By:
- Publication type:
- Article
Quality of life after breast cancer surgery: What have we learned and where should we go next?
- Published in:
- Journal of Surgical Oncology, 2009, v. 99, n. 7, p. 447, doi. 10.1002/jso.21151
- By:
- Publication type:
- Article
Response.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 958, doi. 10.1093/jnci/djs244
- By:
- Publication type:
- Article
Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 159, doi. 10.1093/jnci/djr490
- By:
- Publication type:
- Article
Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62307-5
- By:
- Publication type:
- Article
TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S416, doi. 10.1016/S2152-2650(21)01935-2
- By:
- Publication type:
- Article
Poster: TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01560-3
- By:
- Publication type:
- Article
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient-Reported Symptom Monitoring During Chemotherapy-Reply.
- Published in:
- 2017
- By:
- Publication type:
- letter
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.
- Published in:
- 2017
- By:
- Publication type:
- research
Association of Hospital Participation in a Surgical Outcomes Monitoring Program With Inpatient Complications and Mortality.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 5, p. 505, doi. 10.1001/jama.2015.90
- By:
- Publication type:
- Article
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7545, doi. 10.1245/s10434-021-09816-z
- By:
- Publication type:
- Article
Impact of Zumba on Cognition and Quality of Life is Independent of APOE4 Carrier Status in Cognitively Unimpaired Older Women: A 6-Month Randomized Controlled Pilot Study.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2020, v. 35, p. 1, doi. 10.1177/1533317519868370
- By:
- Publication type:
- Article
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 477, doi. 10.1007/s10549-021-06221-8
- By:
- Publication type:
- Article
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 107, doi. 10.1007/s10549-020-05915-9
- By:
- Publication type:
- Article
Validation of a gastric cancer nomogram using a cancer registry.
- Published in:
- Journal of Surgical Oncology, 2015, v. 112, n. 4, p. 377, doi. 10.1002/jso.23999
- By:
- Publication type:
- Article
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju244
- By:
- Publication type:
- Article
Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju129
- By:
- Publication type:
- Article
Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39).
- Published in:
- Quality of Life Research, 2024, v. 33, n. 7, p. 1985, doi. 10.1007/s11136-024-03675-3
- By:
- Publication type:
- Article
Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 5, p. 1355, doi. 10.1007/s11136-022-03255-3
- By:
- Publication type:
- Article
Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
- Published in:
- Quality of Life Research, 2022, v. 31, n. 4, p. 1069, doi. 10.1007/s11136-021-02968-1
- By:
- Publication type:
- Article
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes.
- Published in:
- Quality of Life Research, 2010, v. 19, n. 10, p. 1395, doi. 10.1007/s11136-010-9759-5
- By:
- Publication type:
- Article
Impact of Personality on Cognitive Aging: A Prospective Cohort Study.
- Published in:
- Journal of the International Neuropsychological Society, 2016, v. 22, n. 7, p. 765, doi. 10.1017/S1355617716000527
- By:
- Publication type:
- Article
Sex-Based Memory Advantages and Cognitive Aging: A Challenge to the Cognitive Reserve Construct?
- Published in:
- Journal of the International Neuropsychological Society, 2015, v. 21, n. 2, p. 95, doi. 10.1017/S1355617715000016
- By:
- Publication type:
- Article
Neuropsychological decline up to 20 years before incident mild cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 3, p. 512, doi. 10.1016/j.jalz.2019.09.085
- By:
- Publication type:
- Article
P1‐480: APOE‐DEPENDENT VERBAL LEARNING EFFECTS IN COGNITIVELY UNIMPAIRED OLDER ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P453, doi. 10.1016/j.jalz.2019.06.1085
- By:
- Publication type:
- Article
P4‐080: SUBJECTIVE COGNITIVE IMPAIRMENT AND THE BROAD AUTISM PHENOTYPE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1466, doi. 10.1016/j.jalz.2018.06.2483
- By:
- Publication type:
- Article